INVACARE SECOND QUARTER RESULTS SPARK 26.6% STOCK ADVANCE IN JULY; ISSUE'S GAIN BUCKS TREND IN CHILLY MONTH FOR OTC DEVICE STOCKS, WHICH SLIDE 7.3%
This article was originally published in The Gray Sheet
Invacare stock stayed on an upward course in July, advancing 26.6% to 29-3/4 on a stronger-than-anticipated second quarter earnings release. The increase helped the stock weather an unseasonably cool July for O-T-C device stocks, which fell sharply for a second consecutive month.
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.